Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,470 public trials 2,851 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

NCT01628029

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +11 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology

NCT05496972

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

UPLC-MS/MS Monitoring of Emicizumab Therapy

NCT04472169

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: CHU de Caen Caen, France

Institut Coeur-Poumon, Pôle d'Hématologie-Transfusion, CHU Lille, France

View Trial Details

Active, not recruiting

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665

Conditions: COVID-19, COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

NCT03747757

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue, +13 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

NCT03613532

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

NCT05102656

Conditions: COVID-19, COVID-19 Infection, Coronaviridae Infections, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab

NCT04302324

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Weill Cornell Medicine - Multiple Myeloma Center New York, United States

View Trial Details

Active, not recruiting

Loncastuximab Tesirine in WM

NCT05190705

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

Fred Hutch Seattle, Washington, United States

View Trial Details

Active, not recruiting

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT05057494

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations: Research Site Tucson, Arizona, United States

Research Site La Jolla, California, United States

Research Site Longmont, Colorado, United States

Research Site Jacksonville, Florida, United States

View all 37 locations

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions